These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7684950

  • 1. Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules.
    Lee TC, Zhang Y, Aston C, Hintz R, Jagirdar J, Perle MA, Burt M, Rom WN.
    Cancer Res; 1993 Jun 15; 53(12):2858-64. PubMed ID: 7684950
    [Abstract] [Full Text] [Related]

  • 2. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II.
    Rutten AA, Bermudez E, Stewart W, Everitt JI, Walker CL.
    Cancer Res; 1995 Aug 15; 55(16):3634-9. PubMed ID: 7627973
    [Abstract] [Full Text] [Related]

  • 3. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
    Fleming JM, Leibowitz BJ, Kerr DE, Cohick WS.
    J Endocrinol; 2005 Jul 15; 186(1):165-78. PubMed ID: 16002546
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT, Schmid C, Ghirlanda-Keller C, Olie R, Winterhalter KH, Zapf J.
    Exp Cell Res; 2001 Dec 10; 271(2):368-77. PubMed ID: 11716549
    [Abstract] [Full Text] [Related]

  • 5. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG, Morgan J, Schwander J, Bleehen NM.
    Cancer Res; 1993 Oct 01; 53(19):4680-5. PubMed ID: 7691401
    [Abstract] [Full Text] [Related]

  • 6. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis.
    Jenkins PJ, Khalaf S, Ogunkolade W, McCarthy K, David T, Hands RE, Davies D, Bustin SA.
    Endocr Relat Cancer; 2005 Dec 01; 12(4):891-901. PubMed ID: 16322329
    [Abstract] [Full Text] [Related]

  • 7. Selective activation of insulin receptor substrate-1 and -2 in pleural mesothelioma cells: association with distinct malignant phenotypes.
    Hoang CD, Zhang X, Scott PD, Guillaume TJ, Maddaus MA, Yee D, Kratzke RA.
    Cancer Res; 2004 Oct 15; 64(20):7479-85. PubMed ID: 15492273
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
    Guo YS, Jin GF, Townsend CM, Zhang T, Sheng HM, Beauchamp RD, Thompson JC.
    J Am Coll Surg; 1995 Aug 15; 181(2):145-54. PubMed ID: 7627387
    [Abstract] [Full Text] [Related]

  • 9. Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer.
    Yee D, Morales FR, Hamilton TC, Von Hoff DD.
    Cancer Res; 1991 Oct 01; 51(19):5107-12. PubMed ID: 1717138
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation.
    Bermont L, Fauconnet S, Lamielle F, Adessi GL.
    Cell Mol Biol (Noisy-le-grand); 2000 Nov 01; 46(7):1173-82. PubMed ID: 11075947
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of IGF-2 and IGF-1 receptor expression in oral cancer cell lines.
    Brady G, Crean SJ, Naik P, Kapas S.
    Int J Oncol; 2007 Oct 01; 31(4):875-81. PubMed ID: 17786320
    [Abstract] [Full Text] [Related]

  • 13. Enhanced expression of dihydrofolate reductase by bovine kidney epithelial cells results in altered cell morphology, IGF-I responsiveness, and IGF binding protein-3 expression.
    Cohick WS, Clemmons DR.
    J Cell Physiol; 1994 Oct 01; 161(1):178-86. PubMed ID: 7523425
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factor binding protein-5 expression by human trabecular meshwork.
    Wirtz MK, Xu H, Rust K, Alexander JP, Acott TS.
    Invest Ophthalmol Vis Sci; 1998 Jan 01; 39(1):45-53. PubMed ID: 9430544
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines.
    Reynolds RK, Hu C, Baker VV.
    Gynecol Oncol; 1998 Aug 01; 70(2):202-9. PubMed ID: 9740691
    [Abstract] [Full Text] [Related]

  • 20. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis.
    Kumar-Singh S, Segers K, Rodeck U, Backhovens H, Bogers J, Weyler J, Van Broeckhoven C, Van Marck E.
    J Pathol; 1997 Jan 01; 181(1):67-74. PubMed ID: 9072005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.